http://orcid.org/0000-0002-4809-2851
Figures
Abstract
Mutations of WD repeat domain 62 (WDR62) lead to autosomal recessive primary microcephaly (MCPH), and down-regulation of WDR62 expression causes the loss of neural progenitor cells (NPCs). However, how WDR62 is regulated and hence controls neurogenesis and brain size remains elusive. Here, we demonstrate that mitogen-activated protein kinase kinase kinase 3 (MEKK3) forms a complex with WDR62 to promote c-Jun N-terminal kinase (JNK) signaling synergistically in the control of neurogenesis. The deletion of Mekk3, Wdr62, or Jnk1 resulted in phenocopied defects, including premature NPC differentiation. We further showed that WDR62 protein is positively regulated by MEKK3 and JNK1 in the developing brain and that the defects of wdr62 deficiency can be rescued by the transgenic expression of JNK1. Meanwhile, WDR62 is also negatively regulated by T1053 phosphorylation, leading to the recruitment of F-box and WD repeat domain-containing protein 7 (FBW7) and proteasomal degradation. Our findings demonstrate that the coordinated reciprocal and bidirectional regulation among MEKK3, FBW7, WDR62, and JNK1, is required for fine-tuned JNK signaling for the control of balanced NPC self-renewal and differentiation during cortical development.
Author summary
Microcephaly is a neural developmental disorder characterized by significantly reduced brain size and variable intellectual disability. WD repeat domain 62 (WDR62) was identified as the second most common gene for autosomal recessive primary microcephaly (MCPH) in human. Here, we studied the underlying regulatory mechanism of WDR62 and the impact on generation of new neurons. We show that mitogen-activated protein kinase kinase kinase 3 (Mekk3), Wdr62, and c-Jun N-terminal kinase 1 (Jnk1) knockout (KO) mice have defects in the generation and maturation of neurons. We demonstrate that WDR62 stability is positively regulated by a mitogen-activated protein kinase kinase kinase (MAPKKK), MEKK3, but negatively regulated by the E3 ligase, F-box and WD repeat domain-containing protein 7 (FBW7). These positive and negative factors calibrate the strength of the activity of the JNK signaling pathway, which controls self-renewal and differentiation of neural progenitor cells (NPCs) during brain development. This finding improves our understanding of the molecular pathogenesis of MCPH.
Citation: Xu D, Yao M, Wang Y, Yuan L, Hoeck JD, Yu J, et al. (2018) MEKK3 coordinates with FBW7 to regulate WDR62 stability and neurogenesis. PLoS Biol 16(12): e2006613. https://doi.org/10.1371/journal.pbio.2006613
Academic Editor: Wange Lu, University of Southern California Keck School of Medicine, United States of America
Received: May 11, 2018; Accepted: November 27, 2018; Published: December 19, 2018
Copyright: © 2018 Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: National Natural Science Foundation (grant number 31430037/31730108/31471132/31571038). Received by ZX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Natural Science Foundation (grant number 31600841). Received by DX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Strategic Priority Research Program and Innovation Program of the Chinese Academy of Sciences (grant number XDBS1020100, XDA16010306, QYZDJ-SSW-SMC007 and GJHZ1827). Received by ZX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shanghai brain-intelligence project from STCSM (grant number 16JC1420500). Received by ZX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beijing brain project (grant number Z161100002616004). Received by ZX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Key research and development program of Hunan province (grant number 2018DK2012). Received by LY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shanghai Science and Technology Committee (grant number 16410723300). Received by BS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Natural Science Foundation (grant number 31470845, 81430033). Received by BS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: ASPM, abnormal spindle-like microcephaly-associated; BrdU, 5-bromo-2’-deoxyuridine; CA, constitutively active; CAS, Chinese Academy of Sciences; CHX, cycloheximide; cKO, conditional knockout; CP, cortical plate; E, embryonic day; EGFP, enhanced green fluorescent protein; FBW7, F-box and WD repeat domain-containing protein 7; GFP, green fluorescent protein; GST, glutathione-S-transferase; HA, influenza hemagglutinin; IGDB, Institute of Genetics and Developmental Biology; IP, immunoprecipitation; IPSC, induced pluripotent stem cell; IZ, intermediate zone; JIP, JNK-interacting protein; JNK, c-Jun N-terminal kinase; KD, knockdown; KO, knockout; MAPKKK, mitogen-activated protein kinase kinase kinase; MCPH, autosomal recessive primary microcephaly; MEKK2, mitogen-activated protein kinase kinase kinase 2; MEKK3, mitogen-activated protein kinase kinase kinase 3; MEKK4, mitogen-activated protein kinase kinase kinase 4; MKK, mitogen-activated protein kinase kinase; MKK4/7, MAP kinase kinase 4/7; NPC, neural progenitor cell; P, postnatal day; POSH, Plenty of SH3; shRNA, short hairpin RNA; SVZ, subventricular zone; VZ, ventricular zone; WDR62, WD repeat domain 62; WT, wild-type
Introduction
Establishment of the mammalian neocortex requires precise control of proliferation and self-renewal of neural progenitor cells (NPCs), as well as the differentiation of NPCs and neuronal migration [1–4]. Defects in these processes lead to brain disorders, including autosomal recessive primary microcephaly (MCPH) [5–8]. During cortical development, the balance between symmetric and asymmetric cell division of NPCs determines the size of the NPC pool for ongoing neurogenesis and ultimately brain size [9–16]. Disturbance in symmetric cell division leads to a reduction in the NPC pool and a falloff of neuron production [10,14,16–19].
MCPH is a neural developmental disorder characterized by significantly reduced brain size and variable intellectual disability [20,21]. Most of the 23 MCPH-associated genes (MCPH1-23) identified so far are predicted to be associated with the mitotic apparatus, such as centrosomes or mitotic spindle poles, at least during part of the cell cycle [6,22–33].
WD repeat domain 62 (WDR62) was identified as a causative gene of MCPH [22–24]. More than 50% of MCPH cases worldwide are caused by mutations in either abnormal spindle-like microcephaly-associated (ASPM) or WDR62 [7,21]. WDR62 has been reported to be a scaffold protein for the c-Jun N-terminal kinase (JNK) signaling pathway by forming a complex with MAP kinase kinases (MKKs) 4 and 7, and JNKs [34,35], similar to what we and other groups have demonstrated for the JNK pathway scaffold proteins such as Plenty of SH3s (POSH) and JNK-interacting proteins (JIPs) [36–39]. We and others have recently shown that WDR62 plays a role in NPC maintenance [40–42]. However, how WDR62 and JNK signaling are regulated for the control of neurogenesis and brain size during brain development is still not clear.
Here, we have identified 2 novel WDR62-interacting proteins: the MAP3K kinase, mitogen-activated protein kinase kinase kinase 3 (MEKK3), and the E3 ubiquitin ligase, F-box and WD repeat domain-containing protein 7 (FBW7). Using in vivo short hairpin RNA (shRNA) knockdown (KD), gene knockout (KO), and transgenic mice, we find that MEKK3, WDR62, and JNK1 play an important role in neurogenesis during cortical development. We demonstrate further that there is synergy between MEKK3 and WDR62 in the activation of JNK signaling while FBW7 negatively regulates the stability of WDR62 through specific phosphorylation of WDR62. Taken together, our findings have revealed the detailed mechanism regulating WDR62 protein levels via interaction with MEKK3 and FBW7, to control proliferation and differentiation of NPCs during brain development. Our study thus unravels a novel molecular mechanism underlying MCPH pathogenesis.
Results
MEKK3 plays an important role in neurogenesis during neocortical development
WDR62 serves as a scaffold for the JNK pathway [34,35] and is critical for the maintenance of NPCs during brain development [40]. MAP3Ks (MKKKs) are important for development and tissue homeostasis and act as central regulators of cell fate during development [43]. To identify potential WDR62 interacting proteins, especially the MKKK that acts upstream of JNK and plays a role in neurogenesis, we screened for neurogenesis-disturbing MAP3Ks with different shRNAs via in utero electroporation at embryonic day 16.5 (E16.5) in rat (Fig 1A and S1 Fig) [40,44]. We found that only MEKK3 (also named MAP3K3) depletion with 3 different shRNAs incurred defects very similar to those resulting from WDR62 KD [40], including a dramatic reduction of NPCs in the proliferative regions of the ventricular and subventricular zones (VZ and SVZ) (Fig 1A). KD of MEKK2 or MEKK4 did not disturb the distribution of cells in a similar way as WDR62 KD (S1 Fig). In addition, we have shown previously that KO or KD of another MKKK, TAK1, only affects the migration of newborn neurons [45].
(A) Coronal sections of rat cortices electroporated in utero with bicistronic constructs encoding both EGFP and MEKK3 shRNAs (shM1, 2, or 3) or control shRNA (Ctrl) at E16.5 and inspected at E20.5. Middle panel: quantification of EGFP+ cell distribution. Data are means ± SEM; ***P < 0.0001; Ctrl, n = 9; shM1 and shM3, n = 6; shM2 n = 8. Right panel: KD efficiency of Mekk3 shRNAs. HA-MEKK3 was cotransfected with shCtrl or shM into HEK293 cells; 24 hours later, cell lysates were analyzed by immunoblotting with anti-HA antibody, with GAPDH as a loading control and GFP to indicate transfection efficiency. (B–E) Coronal sections of E16.5 mice WT or Mekk3 cKO (M-cKO) cortices stained with antibodies against different markers or DAPI as indicated. In panel E, cell-cycle exit index means percent of BrdU+/Ki67- “among all BrdU+”. All data are means ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001. (B) WT and cKO, n = 4. (C) Left panel: WT, n = 5; cKO, n = 3; right panel: WT, n = 7; cKO, n = 3. (D) WT and cKO n = 5. (E) WT, n = 5; cKO, n = 6. n: number of brain slices from different brains. Scale bars: 100 μm (panel A), 50 μm (panels B–E). (F) MEKK3 interacts with WDR62. HEK293 cells were transfected with Flag-MEKK3 and HA-WDR62 cDNA, either alone or in combination. Cell lysates were immunoprecipitated with HA or Flag antibodies and probed with Flag and HA antibodies. (G) Endogenous WDR62 interacts with MEKK3. E14.5 mouse cortical lysates was immunoprecipitated with anti-MEKK3 antibody and probed for MEKK3 and WDR62. Underlying data can be found in S1 Data. BrdU, 5- bromo-2’-deoxyuridine; cKO, conditional knockout; CP, cortical plate; E, embryonic day; EGFP, enhanced green fluorescent protein; HA, influenza hemagglutinin; IgG, Immunoglobulin G; IP, immunoprecipitation; IZ, intermediate zone; KD, knockdown; MEKK3, mitogen-activated protein kinase kinase kinase 3; shRNA, short hairpin RNA; SVZ, subventricular zone; VZ, ventricular zone; WDR62, WD repeat domain 62; WT, wild-type.
MEKK3 is a serine/threonine kinase that can be activated by different signaling pathways. Previous studies showed that MEKK3 is essential for T-cell or cancer cell proliferation [46,47]. The similar defects induced by depletion of MEKK3 and WDR62 suggest that MEKK3, like WDR62, may control NPC proliferation and differentiation. To test this, we crossed the Mekk3flox/flox mice that we generated previously [46] with Nestin-Cre mice to obtain Mekk3flox/flox;Nestin-Cre conditional knockout (Mekk3 cKO) mice in which Mekk3 was deleted in the NPCs. We inspected E16.5 cortical slices with different progenitor cell markers including Pax6 and Sox2 (markers for radial glial cells or apical progenitor cells) and Tbr2 (a marker for intermediate or basal progenitor cells). The thickness of Pax6+, Sox2+, and Tbr2+ cortical layers was reduced significantly in Mekk3 cKO mice, indicating a decrease in NPCs (Fig 1B–1D). In addition, the thinner Pax6+ and Sox2+ cell layers were accompanied by broader cortical staining for Tuj1 (a marker for immature neurons) and decreased numbers of cells positive for phosphor-histone H3 (P-H3, a marker for mitotic activity), respectively (Fig 1B and 1C). Furthermore, we examined the effect of Mekk3 KO on cell-cycle exit index. Both Mekk3 cKO and their wild-type (WT) littermates were labeled at E16.5 with 5-bromo-2’-deoxyuridine (BrdU) to track cells undergoing DNA synthesis. Twenty-four hour later, Ki67 (a marker for proliferating cells) and BrdU+ cells were inspected in brain slices. We observed a substantial decrease in Ki67+ and BrdU+ cells and a significant increase in cell-cycle exit index (cells that had incorporated BrdU but were Ki67−) (Fig 1E), indicating an overall decrease in cell proliferation. Finally, we analyzed cell death in the Mekk3 cKO cortices and did not observe an apparent increase in cell death in the VZ/SVZ (S2 Fig). Taken together, these findings indicate that MEKK3 is required for NPC proliferation and differentiation during cortical development.
MEKK3 interacts with and stabilizes WDR62
Because both MEKK3 and WDR62 are required for neurogenesis, we postulated that MEKK3 might interact with WDR62 to regulate JNK activity and neurogenesis. To test this hypothesis, constructs encoding MEKK3 and WDR62 were transfected into HEK293 cells individually or in combination, and reciprocal coimmunoprecipitation experiments revealed that MEKK3 interacts with WDR62 (Fig 1F). In addition, an anti-MEKK3 antiserum was able to pull down endogenous WDR62 from E14.5 mouse cortex (Fig 1G).
We went on to generate different truncation mutants of WDR62 and MEKK3 in order to identify the potential binding site in MEKK3 and WDR62 (Fig 2A). Using the glutathione-S-transferase (GST)-fused WDR62 truncation mutant (WDR62 C2, aa1018-1523), which includes the MKK and JNK binding domains [34,35], we performed in vitro GST pull-down assays and noticed that MEKK3 could bind to WDR62 C2, but not the WDR62 C1 (aa1314-1523) mutant or GST (Fig 2B). GST pull-down experiment on E14.5 mouse brain lysate was able to pull down endogenous MEKK3 (Fig 2C). These results indicate that WDR62 and MEKK3 association is direct and mapped to 1018–1314 at the WDR62 C-terminal.
(A) Schematic representation of WDR62 and MEKK3 constructs. (B) MEKK3 interacts with WDR62 in vitro. In vitro–transcribed and translated MEKK3 was subjected to pull-down assay with purified GST-fused WDR62 fragments. (C) Purified GST fused C-terminal half of WDR62 pulls down MEKK3 from E14.5 mouse cortical lysate. (D) MEKK3 interacts with different fragments of WDR62. (E) The C-terminal half of MEKK3 interacts with WDR62. (F) Left panel: cells were transfected as indicated. Cell lysates were probed with HA, Flag, and p-JNK, with GAPDH serving as a loading control and GFP as transfection efficiency control. Right panel: quantification of left panel from 3 independent experiments. (G) Vector, WT JNK1, or CAJNK1 was transfected in 293 cells; 24 hours later, cells were collected and analyzed for WDR62 and JNK activity. (H) Left panel: E16.5 cortices from 3 Mekk3 cKO and 3 WT littermates were analyzed for endogenous WDR62 and MEKK3 by western blot. Right panel: quantification of left panel. All data are means ± SEM; **P < 0.01. Underlying data can be found in S1 Data. CA, constitutively active; E, embryonic day; EGFP, enhanced green fluorescent protein; cKO, conditional knockout; GFP, green fluorescent protein; GST, glutathione-S-transferase; HA, influenza hemagglutinin; IP, immunoprecipitation; JNK, c-Jun N-terminal kinase; MEKK3, mitogen-activated protein kinase kinase kinase 3; WDR62, WD repeat domain 62; WT, wild-type.
Because the WDR62 MKK4/7 binding domain was mapped to aa1212-84 [35], the MEKK3 binding domain is likely to be located within aa1018-1212 on WDR62 unless there is an overlap with the MKK4/7 binding domain. Therefore, we characterized in more detail the potential MEKK3 binding motif on WDR62. As shown in Fig 2D, MEKK3 could interact with aa1018-1523, 1018–1314, and 1018–1212 of WDR62. This indicates that the binding motif for MEKK3 in WDR62 is located within aa1018-1212.
The domain structure of MEKK3 consists of a conserved kinase domain and a PB1 domain in the C- and N-terminals, respectively (Fig 2A). Through reciprocal coimmunoprecipitation analysis, we detected that WDR62 interacted with the C-terminal half of MEKK3, but not the N-terminal half of MEKK3 (Fig 2E and S3A Fig). In order to investigate whether a synergistic effect exists between WDR62 and MEKK3, as what has been shown previously for POSH and the MLK family members [36,37], WDR62 and MEKK3 were expressed either alone or in combination in 293 cells. As shown in Fig 2F, when WDR62 and MEKK3 were coexpressed, the level of JNK activity (phosphorylated form of JNK) was significantly enhanced compared to WDR62 or MEKK3 expressed alone. Interestingly, the levels of WDR62 and MEKK3 protein were also much higher when coexpressed (Fig 2F). This suggests that WDR62 and MEKK3 play a synergistic role in the activation of JNK signaling, likely by mutual stabilization of the two proteins.
To determine whether JNK1 is also involved in the regulation of WDR62 levels, downstream of MEKK3, WT JNK1 and a constitutively active form of JNK1 (CA JNK1) were expressed in 293 cells. As shown in Fig 2G, the WDR62 protein level was higher in WT JNK1-expressed cells, and even higher in CA JNK1-expressing cells compared with vector controls, in accordance with the level of JNK activity. Importantly, endogenous WDR62 protein levels were much lower in E16.5 Mekk3 cKO cortices (Fig 2H). However, KD or overexpression of MEKK3 had no significant effect on WDR62 mRNA levels (S3B and S3C Fig). Taken together, the above results indicate that MEKK3 and JNK1 regulate WDR62 expression at the post-transcriptional level.
WDR62 controls neurogenesis and brain size through the regulation of JNK activity
Jnk1 and Jnk2 double-deficient mouse embryos develop exencephaly and die around E11–12 [48]. Jnk1 KO induced pluripotent stem cells (iPSCs) are impaired in their ability to develop into neural precursors in vitro [49]. We have shown previously that JNK1 KD and WDR62 KD cause similar defects during cortical development [40]. We therefore generated a Wdr62 null mutant [50] and investigated further the relationship between WDR62 and JNK activity during brain development. As shown in Fig 3A, the levels of JNK activity were significantly reduced in the Wdr62 mutant cortex as indicated by immunostaining and western blotting, which is consistent with previous findings in different systems [50,51]. We went on to inspect whether KO of Jnk1 would result in similar defects as KO of Wdr62 during cortical development. As observed in Wdr62 mutant mice (Fig 3B), Jnk1 KO brains at E16 also showed enlarged ventricles and a thinner cortex, especially in the VZ/SVZ (Fig 3C). In addition, we observed a significant decrease in Ki67+ cells and an increase in cell-cycle exit index in Jnk1 KO cortices (Fig 3D).
(A) Left panel: coronal sections from E14.5 Wdr62 mutant and WT littermates were stained with p-JNK antibody. Middle panel: Immunoblot analysis of WDR62 and p-JNK levels in E14.5 WT and mutant cortices. Right panel: quantification of p-JNK level from 2 independent experiments. WT n = 3, wdr62 Mut n = 4. (B) Left panel: DAPI staining of coronal section of E18.5 Wdr62 mutant and WT brains. Enlarged views of the cortical area are shown in the middle panel. Right panel: the average cortical thickness was measured at the position of the rectangle. WT n = 20 and Wdr62 mutant n = 22 brain slices in 13 brains. (C) DAPI staining of coronal section of E16.5 Jnk1 KO and WT brains. Enlarged views of the cortical area are shown in the lower panel. (D) Images of the VZ/SVZ of cortices from E16.5 Jnk1 KO or WT littermates labeled with BrdU at E16 and stained for Ki67 and BrdU. Arrowheads mark BrdU+ but Ki67− cells that have exited the cell cycle. Lower panels: quantification of Ki67+ cells and cell-cycle exit index. WT and Jnk1 KO n = 3. (E) Images of the VZ/SVZ of cortices from E17.5 JNK1 cTg or WT littermates labeled with BrdU at E16.5 and stained for Ki67 and BrdU. Lower panels: quantification of cell-cycle exit index and BrdU+ or Ki67+ cells. WT, n = 3; Jnk1 cTg, n = 4. n: number of brain slices from different brains. Scale bars: 50 μm. All data are means ± SEM; ns P > 0.05, *P < 0.05, ***P < 0.001. Underlying data can be found in S1 Data. BrdU, 5-bromo-2’-deoxyuridine; CP, cortical plate; E, embryonic day; JNK1, c-Jun N-terminal kinase 1; ns, not significant; IZ, intermediate zone; KO, knockout; Mut, mutant; SVZ, subventricular zone; VZ, ventricular zone; WDR62, WD repeat domain 62; WT, wild-type.
Because WDR62 regulates JNK activity, we postulated that WDR62 might regulate NPC proliferation and differentiation through JNK1. To test this hypothesis, we investigated whether the defects in Wdr62 mutants can be rescued by JNK1. We first generated conditional transgenic mice expressing CA JNK1 (S4 Fig). The transgenic mice were crossed with Nestin-Cre mice in order to express CA JNK1 in NPCs (JNK1 cTg, hereafter). As observed in cells, CA JNK1 expression increased JNK activity and WDR62 protein level in the cortex (S5A and S5B Fig). We next examined the effect of JNK1 activation on NPC development through BrdU labeling. As shown in Fig 3E, JNK1 cTg cortices showed a significant increase in BrdU+ and Ki67+ cells, while the cell-cycle exit index was comparable between JNK1 cTg and their WT littermates.
Because Wdr62 mutants were sterile [50], we used brain-specific Wdr62flox/flox;Nestin-Cre mice (Wdr62 cKO) for further investigations. Similar to our Wdr62 mutants, Wdr62 cKOs showed reduced brain weight, enlarged ventricles, and a thinner cortex (Fig 4A–4C and S5C and S5D Fig). By crossing Wdr62 cKO with JNK1 cTg mice, we were able to generate Wdr62 cKO, JNK1 cTg, and Wdr62 cKO;JNK1 cTg genotypes. Compared with WT littermates, Wdr62 cKO, but not JNK1 cTg, mice had decreased brain weight at P12. The brain weight of Wdr62 cKO;JNK1 cTg mice was increased compared with Wdr62 cKO mice, and comparable to that of controls (Fig 4B). This indicates that Wdr62 cKO-induced microcephaly can be rescued by increased JNK1 activity. Similarly, JNK1 cTg also rescued the reduced cortex thickness and enlarged lateral ventricle phenotypes in Wdr62 cKO mice (Fig 4C and S5D Fig).
(A) Brain and body weight of P10 Wdr62flox/flox;Nestin-cre (Wdr62 cKO) and WT mice and their ratio of brain weight (BrW) to body weight (BoW). Four Wdr62 cKO and WT littermates were analyzed. (B) Brain weight of P12 mice. Wdr62 cKO, n = 16; JNK1 cTg, n = 4; WT, n = 10 and Wdr62 cKO;JNK1 cTg, n = 10. (C) Coronal sections of E17.5 cortices stained with DAPI. Right panel: quantification of cortical thickness at the position of rectangle. WT n = 9; Wdr62 cKO n = 14; JNK1 cTg n = 7; Wdr62 cKO;JNK1 cTg n = 6. (D) Coronal sections from E17.5 cortices stained with Pax6 and DAPI. Right panel: quantification of Pax6+ cells per section. WT and Wdr62 cKO n = 4; JNK1 cTg and Wdr62 cKO;JNK1 cTg n = 3. (E) Images of cortices from E17.5 littermates labeled with BrdU at E16.5 and stained for Ki67 and BrdU. Right panel: quantification of cell-cycle exit index. WT n = 8; Wdr62 cKO and Wdr62 cKO/JNK1 cTg n = 7. All Data are means ± SEM; ***P < 0.001; **P < 0.01; *P < 0.05; ns P > 0.05; n: number of brain slices from different brains. All scale bars: 50 μm. Underlying data can be found in S1 Data. BoW, body weight; BrdU, 5-bromo-2’-deoxyuridine; BrW, brain weight; cKO, conditional knockout; E, embryonic day; JNK, c-Jun N-terminal kinase; NPC, neural progenitor cell; ns, not significant; P12, postnatal day 12; WDR62, WD repeat domain 62; WT, wild-type.
Because Wdr62 deficiency leads to defects in NPC proliferation and differentiation, we investigated whether those defects could be rescued in Wdr62 cKO;JNK1 cTg mice. As shown in Fig 4D, the number of Pax6+ cells was significantly reduced in Wdr62 cKOs and significantly increased in JNK1 cTgs, while Wdr62 cKO;JNK1 cTg double mutants were comparable to controls. Moreover, we observed a significant increase in cell-cycle exit in Wdr62 cKOs but not in Wdr62 cKO;JNK1 cTg cortices (Fig 4E). Taken together, these findings indicate that WDR62 regulates NPC proliferation and differentiation through JNK1.
FBW7 negatively regulates WDR62 protein stability through the proteasomal pathway
WDR62 and MEKK3 play a synergistic role in the activation of JNK. However, under physiological conditions, a negative regulatory mechanism likely exists to prevent cell death incurred by sustained JNK activation. We noticed that a JNK1-target phosphorylation site in WDR62, T1053 [52], is located within LPQTPEQE, a potential binding motif for the E3 ubiquitin ligase substrate recognition component FBW7. FBW7 plays an opposite role to WDR62 during brain development, promoting rather than antagonizing NPC differentiation [53,54]. This led us to postulate that FBW7 may interact with WDR62 to regulate WDR62 protein stability through the proteasomal pathway. WDR62 was transfected into HEK293 cells either alone or together with the 3 different isoforms of FBW7, FBW7α, β, and γ. Interestingly, WDR62 protein levels appeared lower when coexpressed with FBW7 α or γ in particular, and the reduction could be significantly blocked by MG132 (Fig 5A). We therefore performed a coimmunoprecipitation analysis and detected an interaction of WDR62 with FBW7α and γ but not FBW7β (Fig 5B). In addition, FBW7α interacted with the C-terminal half of WDR62 (WD40Δ) but not the N-terminal half of WDR62 that consists primarily of WD40 domains (Fig 5C). To examine whether FBW7 possesses E3 ligase activity towards WDR62, we assessed WDR62 ubiquitination both in vivo and in vitro. Both FBW7α expression in cells (Fig 5D) and purified FBW7α in an in vitro assay (Fig 5E) induced the ubiquitination of WDR62. To rule out the possibility that the smeared ubiquitin signals were from WDR62-associated proteins, we performed the immunoprecipitation of influenza hemagglutinin (HA)-tagged WDR62, blotted for WDR62, and detected significantly increased upper smear signal when coexpressed with FBW7α and γ but not FBW7β (Fig 5F). Reciprocal immunoprecipitation for HA-ub also pulled out more WDR62 in FBW7α overexpressed cells (Fig 5G). Importantly, WDR62 protein levels were significantly higher in E14.5, E15.5, and E17.5 Fbw7 cKO brains (Fig 5H and S6A and S6B Fig). However, deficiency of FBW7 had no significant effect on WDR62 mRNA level (S6B Fig). These results indicate that Fbw7 negatively regulates WDR62 protein stability through the proteasomal pathway.
(A) Left panel: FBW7α and γ reduces WDR62 protein level. HEK293 cells were transfected as indicated; 16 hours later, cells were treated with MG132 for 4 hours and analyzed by immunoblotting with HA and Flag antibodies. Right panel: quantification of left panel in 3 independent experiments. Relative levels of WDR62 were normalized with GFP. (B) FBW7α and γ interacts with WDR62. Cells transfected as in indicated and were immunoprecipitated with Flag antibody and analyzed. (C) FBW7α interacts with the C-terminal half of WDR62 (WD40Δ). FBW7α was cotransfected with WDR62, WDR62 WD40 (N-terminal half of WDR62) and WDR62 WD40Δ. Cell lysates were immunoprecipitated with HA and analyzed. (D) FBW7α induces WDR62 ubiquitination in cells. HA-WDR62 and Myc-Ub were cotransfected with FBW7α, immunoprecipitated with HA antibody, and probed with Flag and Myc antibodies. (E) FBW7α induces WDR62 ubiquitination in vitro. HA-WDR62 or Flag-FBW7α were expressed in cells, purified by immunoprecipitation and then subjected to in vitro ubiquitination assay. (F) Upper smear signal by immunoblotting with WDR62 indicate stronger ubiquitination of FBW7α. (G) HA-ubi pulled out more WDR62 in WDR62 and FBW7α transfected lyses. (H) E14.5 cortices from 3 Fbw7 cKO and 3 WT littermates were analyzed for endogenous WDR62 with GAPDH as control. All data are means ± SEM; *P < 0.05, **P < 0.01. Underlying data can be found in S1 Data. cKO, conditional knockout; E, embryonic day; FBW7, F-box and WD repeat domain-containing protein 7; GFP, green fluorescent protein; HA, influenza hemagglutinin; WDR62, WD repeat domain 62; WT, wild-type.
Previous study indicates that FBW7 controls neural stem cell differentiation in midbrain [54]. We inspected the distribution of cells in cortex electroporated with Ctrl shRNA, Fbw7 shRNA, Wdr62 shRNA, and Wdr62 shRNA with Fbw7 shRNA. FBW7 KD led to reduced percentage of cells in the SVZ, intermediate zone (IZ), and cortical plate (CP), while WDR62 KD had the opposite phenotype. The phenotype was partially neutralized when Fbw7 shRNA and Wdr62 shRNA were cotransfected together (S6C and S6D Fig). This further supports the notion that WDR62 and FBW7 plays an opposite role in NPC development.
JNK1 induced phosphorylation of WDR62 is important for the ubiquitination of WDR62 by FBW7
We went on to perform a cycloheximide (CHX) time course analysis and found that WDR62 was degraded more rapidly when coexpressed with FBW7α (Fig 6A). We also utilized a WDR62 mutant (PM6, L1299A/L1301A) that is unable to bind to and activate JNKs [55], and compared with WT WDR62, the PM6 mutant was very stable even when coexpressed with FBW7α (Fig 6A), suggesting that the interaction between JNK and WDR62 is important for the destabilization of WDR62.
(A) Left: WT WDR62 or WDR62 PM6 was transfected independently or cotransfected with FBW7α and the half-life of WDR62 was examined by CHX chase assay as indicated. Right: quantification of (left) in 3 independent experiments. (B) The interaction between FBW7α and WDR62 1053A is much weaker. Lower: quantification of (upper) in 2 independent experiments. Relative levels of FBW7 (IP) were normalized with FBW7α (Input). (C) WT WDR62 or WDR62 T1053A and WDR62 T1053D were single transfected or cotransfected with FBW7α, and the half-life of WDR62 was examined by CHX chase assay as indicated. Lower panel: quantification of upper panel in 3 independent experiments. All data are means ± SEM. Underlying data can be found in S1 Data. CHX, cycloheximide; FBW7, F-box and WD repeat domain-containing protein 7; IP, immunoprecipitation; WDR62, WD repeat domain 62; WT, wild-type.
Because JNK1 can induce the phosphorylation of WDR62 T1053 [52], we investigated the role of this modification in WDR62 stability. When WDR62 T1053 was mutated to alanine, its interaction with FBW7 decreased significantly compared with that of WT WDR62 (Fig 6B). We went on to make a phosphomimetic mutant, WDR62 T1053D, and found that it was less stable than WT WDR62, while WDR62 T1053A was more stable when cotransfected with FBW7α (Fig 6C and S7 Fig). We further examined the ubiquitination of WDR62 mutants induced by FBW7. When coexpressed with FBW7, an increased ubiquitination of WT WDR62 but not WDR62 T1053A was detected (Fig 7A and 7B). Consistently, the ubiquitination level of WDR62 T1053D was significantly higher than that of WT WDR62. WDR62 T1053A seemed to be more stable than WT WDR62 and could induce JNK activity more significantly when coexpressed with MEKK3 (Fig 7C).
(A) FBW7 induces more ubiquitination of WDR62 T1053D than WDR62 WT and WDR62 T1053A. (B) FBW7 mediated HA-ubi pull out more WDR62 in T1053D compared with WT and T1053A. (C) HEK293 cells were transfected with WT WDR62 or WDR62 T1053A alone or in combination with MEKK3. 24 hours later, cell lysates were probed with p-WDR62, WDR62, MEKK3, p-JNK, GAPDH, and GFP antibodies. (D) Endogenous WDR62 T1053 phosphorylation declines after exiting M phase (release from nocodazole arrest), is correlated with JNK activity but negatively correlated with WDR62 level. Underlying data can be found in S1 Data. FBW7, F-box and WD repeat domain-containing protein 7; GFP, green fluorescent protein; IP, immunoprecipitation; JNK, c-Jun N-terminal kinase; MEKK3, mitogen-activated protein kinase kinase kinase 3; NZ, nocodazole; WDR62, WD repeat domain 62; WT, wild-type.
JNK activity has been shown to increase during G2 and M phases of the cell cycle and decline after exiting M phase [56]. We arrested HeLa cells in anaphase with nocodazole and then released the cell-cycle arrest. As shown in Fig 7D, JNK activity declined after release from nocodazole arrest, as did the phosphorylation of endogenous WDR62 at T1053. Meanwhile, the level of WDR62 protein increased correspondingly. Taken together, our results indicate that the phosphorylation of WDR62 at T1053 by JNK is critical for its interaction with FBW7 and subsequent ubiquitination and degradation.
Discussion
Several MCPH proteins (ASPM, WDR62, CDK5RAP2, CEP63, CEP135, CEP152, CPAP, MCPH1, and STIL) have been shown to play a role in neurogenesis [7,57–60]. Our study reveals the mechanisms that regulate the stability of MCPH-associated protein WDR62 and NPC proliferation and differentiation during brain development. Specifically, we demonstrate that MEKK3 interacts with WDR62 to stabilize WDR62 and regulates JNK activity in a synergic way. On the other hand, JNK activity also regulates the phosphorylation of WDR62 at T1053 in a feedback loop which facilities the recruitment of FBW7 degradation of WDR62 (Fig 8). In addition, KO of MEKK3 or JNK1 phenocopies WDR62 KO in the dysregulation of NPC development. Transgenic expression of JNK1 can rescue the defects of WDR62, indicating a critical role of JNK signaling pathway in cell fate determination and NPC maintanence.
(A) In the WT brain, the WDR62 scaffold organizes a protein complex including MEKK3, MKK4/7, and JNK1 to control NPC development during corticogenesis (1). The expression of WDR62 is positively regulated by MEKK3 which induced JNK activation (phosphorylation) (blue) (2). It is also negatively regulated subsequently by JNK-induced phosphorylation at T1053 (red) (3). The phosphorylation of WDR62 at T1053 recruits FBW7 to lead to the ubiquitination and degradation of WDR62 through the proteasomal pathway (3), and the down-regulation of JNK activity (4). (B) JNK1 cannot be activated properly in Wdr62, Mekk3, or Jnk1 KO brains, leading to defects in NPC maintenance (possibly due to increase of asymmetric division), which may cause microcephaly. FBW7, F-box and WD repeat domain-containing protein 7; JNK1, c-Jun N-terminal kinase 1; KO, knockout; MEKK3, mitogen-activated protein kinase kinase kinase 3; MKK4/7, MAP kinase kinase 4/7; NPC, neural progenitor cell; WDR62, WD repeat domain 62; WT, wild-type.
MEKK3 cooperates with WDR62 in the regulation of JNK signaling and neurogenesis
Through a functional screen, we have found that MEKK3 KD induces very similar phenotypes as WDR62 KD [40], such as NPC depletion in the embryonic neocortex, suggesting defects in the maintenance of NPC proliferation and the occurrence of premature differentiation. This notion is supported by the significant decrease in cycling cells (Ki67+ and P-H3+) and an increase in cell-cycle exit index in the Mekk3 cKO embryonic neocortex. Meanwhile, we observed a considerable reduction in Pax6-, Sox2-, and Tbr2-positive NPCs accompanied by an increase in Tuj1-positive immature neurons in these mice. Thus, our findings indicate a role for MEKK3 in the proliferation and differentiation of NPC during neurogenesis.
The similar function of MEKK3 and WDR62 led us to explore their relationship and confirm their interaction in the embryonic brain. Interestingly, WDR62 and MEKK3 are likely to play a synergistic role in the activation of JNK signaling as well as in the elevation of each other’s protein levels. In addition, expression of JNK1 elevated WDR62 levels, while endogenous levels of WDR62 were much lower in Mekk3 cKO cortices. Therefore, we can postulate that MEKK3 regulates the protein level of WDR62 through JNK signaling.
JNK signaling is important for cortical neurogenesis
Previous studies have shown that depletion or mutation of several MCPH proteins leads to the premature cell-cycle exit of NPCs and consequently to premature neuronal differentiation or cell death during neurogenesis [42,57,61,62]. Several MCPH proteins such as MCPH1 and ASPM have been shown to regulate the Chk1-Cdc25b and Wnt signaling pathways respectively to control brain size [62,63]. Our studies indicate that the JNK signaling plays a critical role in the normal function of WDR62. First, Jnk1 KO mice have phenotypes very similar to our Wdr62 KO and cKO mice, including premature differentiation of NPCs, enlarged lateral ventricles, and thinner cortices during cortical development. These defects in Wdr62 cKO mice can be largely rescued by the transgenic expression of CA-JNK1. In addition, mice with deletion of kinases upstream of JNK1 have phenotypes somewhat similar to Wdr62 and Jnk1 mutants. For example, brain-specific Mkk7 or Mkk4 KO mice display either enlarged embryonic brain ventricles or reduced brain size [64]. Taken together, all these studies imply that WDR62 cooperates with MEKK3, MKKs, and JNK1 in the regulation of brain development.
FBW7 negatively regulates WDR62 stability through the proteasomal pathway
The E3 ligase FBW7 is important for normal brain development, and KO of Fbw7 inhibits NPC differentiation [54], the opposite defect of that caused by Wdr62 KO. We have confirmed the interaction between WDR62 and FBW7. Interestingly, WDR62 T1053, which is phosphorylated by JNK1 and localizes within the FBW7 binding motif of WDR62, is important for the interaction between WDR62 and FBW7. In addition, phosphorylation of T1053 is crucial for the regulation of WDR62 stability by FBW7, through ubiquitination and degradation of WDR62.
Previous studies have shown that WDR62 protein level is cell-cycle dependent [22,52]. However, the underlying mechanism is unknown. Two mutants—WDR62 L1299A/L1301A, which cannot bind to JNK, and WDR62 T1053A—are more stable than WT WDR62, indicating the involvement of JNK signaling in the regulation WDR62 expression. JNK activity increases during G2 and M phases of cell cycle [56]. Intriguingly, the level of WDR62 phosphorylated at T1053 declines after cells are released from nocodazole arrest (M anaphase). This is accompanied by the decline in JNK activity and the elevation of WDR62 level, indicating that phosphorylation of T1053 is negatively correlated with WDR62 stability. We would like to propose a model (Fig 8) that JNK activation at G2/M phase leads to WDR62 phosphorylation at T1053, which will recruit FBW7 to induce the ubiquitination and degradation of WDR62. As the cell cycle progresses, JNK activity declines, and newly synthesized WDR62 will accumulate. Through the interaction with MEKK3, WDR62 is stabilized and promotes activation of JNK at G2/M phase. Thus, JNK-induced phosphorylation of T1053 is also likely to play a critical role in recruiting FBW7 and the degradation of WDR62 during cell-cycle progression. How MEKK3 and JNK1 stabilize WDR62 and activate JNK needs to be explored in the future.
Taken together, our results support a model in which the scaffold protein WDR62 organizes a protein complex that includes MEKK3, MKKs, and JNK1 to control the proliferation and differentiation of NPCs during corticogenesis (Fig 8). The expression of WDR62 is fine-tuned both positively by MEKK3 and JNK activity and negatively by JNK-induced phosphorylation of WDR62 at T1053. Thus, the coordinated reciprocal and bidirectional regulation among WDR62, MEKK3, JNK1, and FBW7 fine-tunes JNK signaling to control the balance between proliferation and differentiation of NPCs and prevent superfluous cell death incurred by sustained JNK activation during brain development.
Materials and methods
Ethics statement
All animal procedures used in this study were performed according to protocols approved by the Institutional Animal Care and Use Committee at the Institute of Genetics and Developmental Biology (IGDB), Chinese Academy of Sciences (CAS) (protocol number: AP2016053).
Antibodies
The antibodies used for western blotting (for human) were as follows: GFP (abcam, ab290, 1:2,000), α-tubulin (CST, 3873s, 1:2,000), GAPDH (CST, 2118s, 1:2,000), Flag (MBL, M185, 1:2,000), Myc (MBL, M047-3, 1:5,000), HA (MBL, M180-3, 1:5,000), Phospho-JNK (CST, 9255, 1:1,000), and WDR62 (bethyl, A310-550A, 1:1,000). For mouse, they were as follows: WDR62 (abcam, 1:1,000), WDR62 antibody generated by MBL company using antigen VGQGGNQPKAGPLRAGTC, Phospho-WDR62 1053T (present from Dominic) [52], and MEKK3 (CST, 5727, 1:1,000). The antibodies used for immunostaining were Sox2 (abcam, ab97959, 1:1,000), Pax6 (Covance, PRB-278P, 1:400), Tbr2 (Millipore, ab2283, 1:1,000), β-III Tubulin/Tuj1 (abcam, ab7751, 1:1,000), γ-Tubulin (abcam, ab11316, 1:1,000), α-Tubulin (CST, 3873, 1:2,000), Phosph-Histone 3 (P-H3) (abcam, ab10543, 1:1,000), Nestin (abcam, ab6142, 1:1,000), GFP (abcam, ab13970, 1:1,000), Ki67 (abcam, ab15580, 1:1,000), BrdU (abcam, ab6326, 1:500), Phospho-JNK (abcam, ab124956, 1:1,000), activated-caspase3 (abcam, ab13847, 1:1,000). Nuclei were stained with DAPI (4’,6-diamidino-2-phenylindole) (Invitrogen).
Plasmids
Human WDR62 WT, WD40 and WD40Δ truncations, or WDR62 mutants were created by cloning WDR62 cDNA sequence into the pCMS.EGFP (modified) (Flag) or pCDNA3.1-HA vector. Full-length MEKK3, MEKK3 N- and MEKK3 C-terminal truncations were cloned into the pCMV-Tag2B vector. Full-length MEKK3 was also cloned into the pCMS.EGFP (modified) (Flag) or pCDNA3.1-HA vector. For GST pull-down assay, full-length WDR62, WDR62 C2 (1018-1523aa), or WDR62 C1 (1314-1523aa) were cloned into pGEX6p1. Flag-FBW7α, β, and γ in pCDNA3.1 were kindly provided by Dr. Clurman [65]. All constructs were verified by sequencing.
Generation of KO and transgenic mice
Wdr62 cKO mice.
Wdr62+/flox mouse and Wdr62 mutant (Wdr62−/−) mice were generated as described previously [50]. Wdr62 cKO (Wdr62flox/flox; Nestin-Cre) mice were obtained by crossing Nestin–Cre mice with Wdr62flox/flox mice.
CA-JNK1 conditional transgenic mice.
An HA-tagged human JNKK2-JNK1 fusion construct was inserted into the pENTR1A vector (Life Technologies) as described in S4A Fig. To guarantee controlled and efficient monosite insertion of JNKK2-JNK1 into the ubiquitously expressed ROSA26 locus, we used the Gateway Entry system (Life Technologies) (S4B Fig) [66]. Mice carrying the conditional floxed (loxP-STOP-loxP; LSL) LSL-CA-JNK1 f/f allele were crossed with Nestin-Cre mice to generate mice expressing CA-JNK1 in NPCs (JNK1 cTg).
Wdr62 cKO;JNK1 cTg mice.
By crossing Wdr62 cKO with JNK1 cTg mice, we were able to get Wdr62 cKO, JNK1 cTg, and Wdr62 cKO;JNK1 cTg mice.
Mekk3 cKO.
Mice carrying the conditional (floxed, Mekk3f/f) allele [46] were crossed with Nestin-Cre mice to generate mice with a specific deletion in NPC (Mekk3 cKO). Jnk1 heterozygous (Jnk1+/−) KO mice (stock# 003553) were obtained from the Jackson Laboratory.
The day when a plug was observed in a female mouse was designated E0.5, and the day of birth was termed postnatal day 0 (P0). Mouse genotypes were determined by PCR. For all experiments, only littermate mice from the same breeding were used.
Histology and immunofluorescence staining
For cryosections, tissues were fixed in 4% PFA, cryoprotected in 30% sucrose, and frozen in tissue freezing medium (TFM). Sections (thickness of 20–50 μm) were used for immunofluorescence staining. Immunofluorescence staining was carried out essentially as described previously [44,67].
BrdU labeling
For single-pulse BrdU labeling, pregnant mice at defined pregnancy stages were injected intraperitoneally with 50 mg/g body weight of BrdU (Sigma-Aldrich) and were euthanized 12 to 24 hours after injection.
Cell culture, transfection, immunoprecipitation, and western blotting
HEK293 cell culture, transfection, immunoprecipitation, and western blotting were performed as previously described [36]. Plasmids were transfected into HEK293 cells with VigoFect (VIGOROUS). For western blot of Figs 5F, 5G and 7B and S7 Fig, cells were treated with 20 μm MG132 for 4 hours before lyses (MG132 added). Densitometric analysis was performed using Image J software. The relative Integrated Density of western blot band was measured.
In utero electroporation
In utero electroporation was performed as previously described [67]. Pregnant Sprague Dawley rats were provided by the animal center of IGDB. Rat Mekk3 shRNA vector containing the following target sequences was used: shM1: 5’-GCCTTAGGATACTACTGTTA-3’; shM2: 5’-GCAGCAACATGATTGTGCA-3’; and shM3, 5’-GATCACAAAGACTACAATGA-3’. The human MEKK3 shRNA target sequence was 5’-GCAGAGTGACGTCAGAATC-3’. The rat Mekk2 shRNA target sequence was as follows: shRNA1: 5’-GAGCGAATTGTTCAGTATTA-3’; shRNA2: 5’-GAAGCAATGGCTGCCATCT-3’; and shRNA3: 5’-GCTGGATCCATTGTCTTTA-3’. The rat Mekk4 shRNA target sequence was as follows: shRNA1: 5’-GAGGAAGCTGGATCCAAATG-3’; shRNA2: 5’-GAGTATCATAAAGAAGTTG-3’; and shRNA3: 5’-GCCTTTATTTCAGCTTTAC-3’. The rat Fbw7 shRNA target sequence was 5’-CCTTCTCTGGAGAGAGAAA-3’.
Statistical analysis
Sections were imaged on an LSM 700 (Carl Zeiss) confocal microscope as described [40]. Cell counts were analyzed with Imaris X64 or ImageJ. All data were analyzed using Excel and Prism software (Graph Pad Software, La Jolla, CA). Tests used were unpaired t test or one-way ANOVA paired with Tukey post-test.
Supporting information
S1 Data. Individual numerical values that underlie data displayed in Figs 1A–1E, 2F, 2H, 3A–3E, 4A–4E, 5A, 5H, 6A–6C and 7D, and S1B, S3B, S3C, S5B–S5D, S6B and S6D Figs.
https://doi.org/10.1371/journal.pbio.2006613.s001
(XLSX)
S1 Fig. MEKK2 and MEKK4 KD do not show the same phenotype as MEKK3 KD.
(A) Coronal sections of rat cortices electroporated in utero with bicistronic constructs encoding both EGFP and MEKK2, MEKK4 shRNAs or control shRNA (Ctrl) at E16.5 and inspected at E20.5. (B) Quantification of cell distribution of EGFP+ cells. Data are means ± SEM; *P < 0.05. Ctrl, n = 8; Mekk2 sh1, n = 5; Mekk2 sh2, n = 7; Mekk2 sh3, n = 10; Mekk4 sh1, n = 5; Mekk4 sh3, n = 6. n: brain slices from more than 3 independent brains. Scale bar: 50 μm. (C) KD efficiency of Mekk2/Mekk4 shRNAs. HA-MEKK2, MEKK4 cDNAs were cotransfected with shCtrl or shRNAs into HEK293 cells; 48 h later, cell lysates were analyzed by immunoblotting with anti-HA antibody, with GAPDH/Tubulin serving as a loading control and GFP as a transfection efficiency control. Underlying data can be found in S1 Data. Ctrl, control; E, embryonic day; EGFP, enhanced green fluorescent protein; HA, influenza hemagglutinin; KD, knockdown; MEKK2, mitogen-activated protein kinase kinase kinase 2; MEKK4, mitogen-activated protein kinase kinase kinase 4; SC, scramble; shRNA, short hairpin RNA.
https://doi.org/10.1371/journal.pbio.2006613.s002
(TIF)
S2 Fig. Images of E17.5 brain slices from WT and Mekk3 cKO mice stained for the activated form of caspase 3 (green) and DAPI (blue).
Scale bar: 50 μm. cKO, conditional knockout; E, embryonic day; MEKK3, mitogen-activated protein kinase kinase kinase 3; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2006613.s003
(TIF)
S3 Fig. MEKK3 interact with WDR62 and does not affect the mRNA levels of WDR62.
(A) Reciprocal immunoprecipitation of Fig 2E. (B) Relative WDR62 mRNA expression in MEKK3 KD cells. HEK293 cells were transfected with scramble control or human MEKK3 shRNA; 48 hours later, cells were collected for qPCR analysis. (C) Relative endogenous WDR62 mRNA expression in human MEKK3 overexpression cells. HEK293 cells were transfected with vector or HA-human MEKK3; 24 hours later, cells were collected for qPCR analysis. Underlying data can be found in S1 Data. HA, influenza hemagglutinin; IP, immunoprecipitation; MEKK3, mitogen-activated protein kinase kinase kinase 3; qPCR, quantitative PCR; shRNA, short hairpin RNA; WDR62, WD repeat domain 62.
https://doi.org/10.1371/journal.pbio.2006613.s004
(TIF)
S4 Fig. Generation of JNK1 conditional transgenic mice.
(A) Schematic of the JNKK2-JNK1 fusion constructs. The construct consists of a 3xHA tag, the human JNKK2 cDNA, (Gly-Gly) 5 repeats and the human JNK1 cDNA. The JNKK2-JNK1 fusion construct was inserted into the multiple cloning site of the pENTR1A vector (Life Technologies). (B) Targeting of the genomic ROSA26 locus with the JNKK2-JNK1 vector. In the pEntry clone, the JNKK2-JNK1 construct is flanked by lambda phage integrase recognition sites (attL) and thus can be efficiently inserted into the targeting vector carrying the corresponding heterotypic sites (attR). The targeting construct consists of a 5’-ROSA26 homology arm, a splice acceptor (SA) site, a PGK-neo-STOP cassette flanked by loxP-site (LSL), the JNKK2-JNK1 fusion construct, an IRES-eGFP reporter gene, a 3’-ROSA26 homology arm, and a PGK-DTA selection cassette. Screening PCR was performed using a forward primer indicated by arrow 1 and reverse primer indicated by arrow 2 in the 5’ region of the targeting construct. After Cre-mediated recombination, the LSL cassette is excised, and the JNKK2-JNK1 fusion construct is expressed in the genomic ROSA26 locus. For genotyping PCR, primers indicated by arrows 3, 4 located in the eGFP reporter gene were used. Arrowheads indicate loxP-sites. Underlying data can be found in S1 Data. eGFP, enhanced green fluorescent protein; HA, influenza hemagglutinin; IRES, internal ribosome entry site; JNK, c-Jun N-terminal kinase.
https://doi.org/10.1371/journal.pbio.2006613.s005
(TIF)
S5 Fig.
(A) Western blot analysis of JNK1 expression in the WT, JNK1 cTg, Wdr62 cKO, and Wdr62cKO;JNK1 cTg brains at E14.5. GAPDH was used as a loading control. (B) Western blot analysis of WDR62 expression in the E16.5 WT and JNK1 cTg mice brain. Right panels: quantification of WDR62 protein and mRNA expression. WT, n = 3; JNK1 cTg, n = 2. (C) Body and brain weight of P3 Wdr62flox/flox;Nestin-cre (Wdr62 cKO) and WT mice. Three Wdr62 cKO and WT littermates were analyzed. (D) Quantification of ventricle area as a percentage of whole telencephalon area. WT, n = 10; Wdr62 cKO, n = 14; JNK1 cTg, n = 7; Wdr62 cKO;JNK1 cTg, n = 6. n: brain numbers. All data are means ± SEM; ***P < 0.001, *P < 0.05, ns P > 0.05. Underlying data can be found in S1 Data. cKO, conditional knockout; E, embryonic day; JNK1, Jun N-terminal kinase 1; ns, not significant; WDR62, WD repeat domain 62; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2006613.s006
(TIF)
S6 Fig. FBW7 regulates WDR62 stability at protein level.
(A) E17.5 or E15.5 cortices from Fbw7 cKO and WT littermates were analyzed by western blot for endogenous WDR62 with GAPDH as control. (B) Left panel: quantification of WDR62 protein levels compared to WT control in panel A. Middle and right panel: relative Fbw7 and Wdr62 mRNA expression in 3 Fbw7 cKO and 5 WT mice. (C) Coronal sections of rat cortices electroporated in utero with bicistronic constructs encoding both EGFP and Wdr62 shRNA, Fbw7 shRNA or control shRNA (Ctrl) at E16.5 and inspected at E20.5. Scale bar 50 μm. In E20.5 cortex: “ML” indicates the mantle layer, including the cortical SVZ, IZ, and CP. (D) Relative quantity of cells in VZ and ML in panel C. Scramble, n = 6; Wdr62 shRNA1 (Wdr62sh1), n = 7; Fbw7 shRNA1 (Fbw7 sh1), fbw7 sh1; wdr62 sh1, n = 8. All data are means ± SEM; ***P < 0.001, **P < 0.01, *P < 0.05, ns P > 0.05. Underlying data can be found in S1 Data. CP, cortical plate; E, embryonic day; FBW7, F-box and WD repeat domain-containing protein 7; IZ, intermediate zone; ML, mantle layer; ns, not significant; SVZ, subventricular zone; VZ, ventricular zone; WDR62, WD repeat domain 62; WT, wild-type.
https://doi.org/10.1371/journal.pbio.2006613.s007
(TIF)
S7 Fig. WDR62 T1053 is critical for FBW7-mediated degradation.
WDR62 T1053A showed weak interaction with FBW7 compared with WDR62 WT. HEK293 cells were transfected with Flag-WDR62 and Flag-WDR62-T1053A either alone or in combination with HA-FBW7α; 16 hours later, cells were treated with MG132 for 4 hours. Cell lysates were immunoprecipitated with HA antibody and probed with HA or WDR62 antibodies. FBW7, F-box and WD repeat domain-containing protein 7; HA, influenza hemagglutinin; WDR62, IP, immunoprecipitation; WD repeat domain 62.
https://doi.org/10.1371/journal.pbio.2006613.s008
(TIF)
Acknowledgments
We would like to thank Drs. Z. Wang and C. Cremona for their constructive advice regarding the manuscript and Q. Shen, H. Song, X. Wang, and Y. Zou for their constructive comments. We also thank Dr. R. Davis for the WT and CA JNK1 constructs, Dr. Clurman for FBW7 constructs, and Dr. P. Wang for Fbw7flox/flox mice.
References
- 1. Hu WF, Chahrour MH, Walsh CA. The diverse genetic landscape of neurodevelopmental disorders. Annu Rev Genomics Hum Genet. 2014;15:195–213. https://doi.org/10.1146/annurev-genom-090413-025600. pmid:25184530.
- 2. Gotz M, Huttner WB. The cell biology of neurogenesis. Nat Rev Mol Cell Biol. 2005;6(10):777–88. https://doi.org/10.1038/nrm1739. pmid:16314867.
- 3. Breunig JJ, Haydar TF, Rakic P. Neural stem cells: historical perspective and future prospects. Neuron. 2011;70(4):614–25. https://doi.org/10.1016/j.neuron.2011.05.005. pmid:21609820.
- 4. Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci. 2009;32:149–84. https://doi.org/10.1146/annurev.neuro.051508.135600. pmid:19555289.
- 5. Kaindl AM, Passemard S, Kumar P, Kraemer N, Issa L, Zwirner A, et al. Many roads lead to primary autosomal recessive microcephaly. Prog Neurobiol. 2010;90(3):363–83. https://doi.org/10.1016/j.pneurobio.2009.11.002. pmid:19931588.
- 6. Manzini MC, Walsh CA. What disorders of cortical development tell us about the cortex: one plus one does not always make two. Curr Opin Genet Dev. 2011;21(3):333–9. https://doi.org/10.1016/j.gde.2011.01.006. pmid:21288712.
- 7. Thornton GK, Woods CG. Primary microcephaly: do all roads lead to Rome? Trends in Genetics. 2009;25(11):501–10.https://doi.org/10.1016/j.tig.2009.09.011. pmid:19850369.
- 8. Yang YJ, Baltus AE, Mathew RS, Murphy EA, Evrony GD, Gonzalez DM, et al. Microcephaly gene links trithorax and REST/NRSF to control neural stem cell proliferation and differentiation. Cell. 2012;151(5):1097–112. https://doi.org/10.1016/j.cell.2012.10.043. pmid:23178126.
- 9. Knoblich JA. Mechanisms of asymmetric stem cell division. Cell. 2008;132(4):583–97. https://doi.org/10.1016/j.cell.2008.02.007. pmid:18295577.
- 10. Wang X, Lui JH, Kriegstein AR. Orienting fate: spatial regulation of neurogenic divisions. Neuron. 2011;72(2):191–3. https://doi.org/10.1016/j.neuron.2011.10.003. pmid:22017981.
- 11. Franco SJ, Muller U. Shaping Our Minds: Stem and Progenitor Cell Diversity in the Mammalian Neocortex. Neuron. 2013;77(1):19–34. https://doi.org/10.1016/j.neuron.2012.12.022. pmid:23312513.
- 12. Huttner WB, Kosodo Y. Symmetric versus asymmetric cell division during neurogenesis in the developing vertebrate central nervous system. Curr Opin Cell Biol. 2005;17(6):648–57. https://doi.org/10.1016/j.ceb.2005.10.005. pmid:16243506.
- 13. Hu DJ, Baffet AD, Nayak T, Akhmanova A, Doye V, Vallee RB. Dynein recruitment to nuclear pores activates apical nuclear migration and mitotic entry in brain progenitor cells. Cell. 2013;154(6):1300–13. https://doi.org/10.1016/j.cell.2013.08.024. pmid:24034252.
- 14. Miyata T, Kawaguchi D, Kawaguchi A, Gotoh Y. Mechanisms that regulate the number of neurons during mouse neocortical development. Curr Opin Neurobiol. 2010;20(1):22–8. https://doi.org/10.1016/j.conb.2010.01.001. pmid:20138502.
- 15. Shen Q, Wang Y, Dimos JT, Fasano CA, Phoenix TN, Lemischka IR, et al. The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells. Nat Neurosci. 2006;9(6):743–51. https://doi.org/10.1038/nn1694. pmid:16680166.
- 16. Miller FD, Gauthier AS. Timing is everything: making neurons versus glia in the developing cortex. Neuron. 2007;54(3):357–69. https://doi.org/10.1016/j.neuron.2007.04.019. pmid:17481390.
- 17. Dehay C, Kennedy H. Cell-cycle control and cortical development. Nat Rev Neurosci. 2007;8(6):438–50. https://doi.org/10.1038/nrn2097. pmid:17514197.
- 18. Paridaen JT, Huttner WB. Neurogenesis during development of the vertebrate central nervous system. EMBO Rep. 2014;15(4):351–64. https://doi.org/10.1002/embr.201438447. pmid:24639559.
- 19. He S, Nakada D, Morrison SJ. Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol. 2009;25:377–406. https://doi.org/10.1146/annurev.cellbio.042308.113248. pmid:19575646.
- 20. Gilmore EC, Walsh CA. Genetic causes of microcephaly and lessons for neuronal development. Wiley Interdiscip Rev Dev Biol. 2013;2(4):461–78. https://doi.org/10.1002/wdev.89. pmid:24014418.
- 21. Woods CG, Basto R. Microcephaly. Curr Biol. 2014;24(23):R1109–11. https://doi.org/10.1016/j.cub.2014.09.063. pmid:25465325.
- 22. Nicholas AK, Khurshid M, Desir J, Carvalho OP, Cox JJ, Thornton G, et al. WDR62 is associated with the spindle pole and is mutated in human microcephaly. Nat Genet. 2010;42(11):1010–4. https://doi.org/10.1038/ng.682. pmid:20890279.
- 23. Yu TW, Mochida GH, Tischfield DJ, Sgaier SK, Flores-Sarnat L, Sergi CM, et al. Mutations in WDR62, encoding a centrosome-associated protein, cause microcephaly with simplified gyri and abnormal cortical architecture. Nat Genet. 2010;42(11):1015–20. https://doi.org/10.1038/ng.683. pmid:20890278.
- 24. Bilguvar K, Ozturk AK, Louvi A, Kwan KY, Choi M, Tatli B, et al. Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations. Nature. 2010;467(7312):207–10. https://doi.org/10.1038/nature09327. pmid:20729831.
- 25. Wollnik B. A common mechanism for microcephaly. Nat Genet. 2010;42(11):923–4. https://doi.org/10.1038/ng1110-923. pmid:20980985.
- 26. Khan MA, Rupp VM, Orpinell M, Hussain MS, Altmuller J, Steinmetz MO, et al. A missense mutation in the PISA domain of HsSAS-6 causes autosomal recessive primary microcephaly in a large consanguineous Pakistani family. Hum Mol Genet. 2014;23(22):5940–9. https://doi.org/10.1093/hmg/ddu318. pmid:24951542.
- 27. Insolera R, Bazzi H, Shao W, Anderson KV, Shi SH. Cortical neurogenesis in the absence of centrioles. Nat Neurosci. 2014;17(11):1528–35. https://doi.org/10.1038/nn.3831. pmid:25282615.
- 28. Martin CA, Ahmad I, Klingseisen A, Hussain MS, Bicknell LS, Leitch A, et al. Mutations in PLK4, encoding a master regulator of centriole biogenesis, cause microcephaly, growth failure and retinopathy. Nat Genet. 2014. https://doi.org/10.1038/ng.3122. pmid:25344692.
- 29. Mirzaa GM, Vitre B, Carpenter G, Abramowicz I, Gleeson JG, Paciorkowski AR, et al. Mutations in CENPE define a novel kinetochore-centromeric mechanism for microcephalic primordial dwarfism. Hum Genet. 2014;133(8):1023–39. https://doi.org/10.1007/s00439-014-1443-3. pmid:24748105.
- 30. Shohayeb B, Lim NR, Ho U, Xu Z, Dottori M, Quinn L, et al. The Role of WD40-Repeat Protein 62 (MCPH2) in Brain Growth: Diverse Molecular and Cellular Mechanisms Required for Cortical Development. Mol Neurobiol. 2017. https://doi.org/10.1007/s12035-017-0778-x. pmid:28940170.
- 31. Kadir R, Harel T, Markus B, Perez Y, Bakhrat A, Cohen I, et al. ALFY-Controlled DVL3 Autophagy Regulates Wnt Signaling, Determining Human Brain Size. PLoS Genet. 2016;12(3):e1005919. https://doi.org/10.1371/journal.pgen.1005919. pmid:27008544.
- 32. Moawia A, Shaheen R, Rasool S, Waseem SS, Ewida N, Budde B, et al. Mutations of KIF14 cause primary microcephaly by impairing cytokinesis. Ann Neurol. 2017;82(4):562–77. https://doi.org/10.1002/ana.25044. pmid:28892560.
- 33. Cabello OA, Eliseeva E, He WG, Youssoufian H, Plon SE, Brinkley BR, et al. Cell cycle-dependent expression and nucleolar localization of hCAP-H. Mol Biol Cell. 2001;12(11):3527–37. https://doi.org/10.1091/mbc.12.11.3527. pmid:11694586.
- 34. Wasserman T, Katsenelson K, Daniliuc S, Hasin T, Choder M, Aronheim A. A novel c-Jun N-terminal kinase (JNK)-binding protein WDR62 is recruited to stress granules and mediates a nonclassical JNK activation. Mol Biol Cell. 2010;21(1):117–30. https://doi.org/10.1091/mbc.E09-06-0512. pmid:19910486.
- 35. Cohen-Katsenelson K, Wasserman T, Khateb S, Whitmarsh AJ, Aronheim A. Docking interactions of the JNK scaffold protein WDR62. Biochem J. 2011;439(3):381–90. https://doi.org/10.1042/BJ20110284. pmid:21749326.
- 36. Xu ZH, Kukekov NV, Greene LA. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis. EMBO J. 2003;22(2):252–61. https://doi.org/10.1093/emboj/cdg021. pmid:12514131.
- 37. Xu Z, Kukekov NV, Greene LA. Regulation of apoptotic c-Jun N-terminal kinase signaling by a stabilization-based feed-forward loop. Mol Cell Biol. 2005;25(22):9949–59. https://doi.org/10.1128/MCB.25.22.9949-9959.2005. pmid:16260609.
- 38. Kukekov NV, Xu Z, Greene LA. Direct interaction of the molecular scaffolds POSH and JIP is required for apoptotic activation of JNKs. J Biol Chem. 2006;281(22):15517–24. https://doi.org/10.1074/jbc.M601056200. pmid:16571722.
- 39. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103(2):239–52. pmid:11057897.
- 40. Xu D, Zhang F, Wang Y, Sun Y, Xu Z. Microcephaly-associated protein WDR62 regulates neurogenesis through JNK1 in the developing neocortex. Cell Rep. 2014;6(1):104–16. https://doi.org/10.1016/j.celrep.2013.12.016. pmid:24388750.
- 41. Chen JF, Zhang Y, Wilde J, Hansen KC, Lai F, Niswander L. Microcephaly disease gene Wdr62 regulates mitotic progression of embryonic neural stem cells and brain size. Nat Commun. 2014;5:3885. https://doi.org/10.1038/ncomms4885. pmid:24875059.
- 42. Jayaraman D, Kodani A, Gonzalez DM, Mancias JD, Mochida GH, Vagnoni C, et al. Microcephaly Proteins Wdr62 and Aspm Define a Mother Centriole Complex Regulating Centriole Biogenesis, Apical Complex, and Cell Fate. Neuron. 2016;92(4):813–28. https://doi.org/10.1016/j.neuron.2016.09.056. pmid:27974163.
- 43. Craig EA, Stevens MV, Vaillancourt RR, Camenisch TD. MAP3Ks as Central Regulators of Cell Fate During Development. Dev Dyn. 2008;237(11):3102–14. https://doi.org/10.1002/Dvdy.21750. pmid:18855897.
- 44. Zhang F, Xu D, Yuan L, Sun Y, Xu Z. Epigenetic regulation of Atrophin1 by lysine-specific demethylase 1 is required for cortical progenitor maintenance. Nat Commun. 2014;5:5815. https://doi.org/10.1038/ncomms6815. pmid:25519973.
- 45. Zhang F, Yu J, Yang T, Xu D, Chi Z, Xia Y, et al. A Novel c-Jun N-terminal Kinase (JNK) Signaling Complex Involved in Neuronal Migration during Brain Development. J Biol Chem. 2016;291(22):11466–75. https://doi.org/10.1074/jbc.M116.716811. pmid:27026702.
- 46. Wang XF, Chang X, Facchinetti V, Zhuang Y, Su B. MEKK3 Is Essential for Lymphopenia-Induced T Cell Proliferation and Survival. J Immunol. 2009;182(6):3597–608. https://doi.org/10.4049/jimmunol.0803738. pmid:19265138.
- 47. Santoro R, Zanotto M, Carbone C, Piro G, Tortora G, Melisi D. MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity. Anticancer Res. 2018;38(4):1937–46. https://doi.org/10.21873/anticanres.12431. pmid:29599309.
- 48. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron. 1999;22(4):667–76. pmid:10230788.
- 49. Zhang Q, Mao J, Zhang X, Fu H, Xia S, Yin Z, et al. Role of Jnk1 in development of neural precursors revealed by iPSC modeling. Oncotarget. 2016;7(38):60919–28. https://doi.org/10.18632/oncotarget.11377. pmid:27556303.
- 50. Zhou Y, Qin Y, Qin YY, Xu BY, Guo T, Ke HN, et al. Wdr62 is involved in meiotic initiation via activating JNK signaling and associated with POI in humans. PLoS Genet. 2018;14(8). https://doi.org/10.1371/journal.pgen.1007463. pmid:30102701.
- 51. Prinz E, Aviram S, Aronheim A. WDR62 mediates TNFalpha dependent JNK activation via TRAF2-MLK3 axis. Mol Biol Cell. 2018:mbcE17080504. https://doi.org/10.1091/mbc.E17-08-0504. pmid:30091641.
- 52. Lim NR, Yeap YY, Zhao TT, Yip YY, Wong SC, Xu D, et al. Opposing roles for JNK and Aurora A in regulating the association of WDR62 with spindle microtubules. J Cell Sci. 2015;128(3):527–40. https://doi.org/10.1242/jcs.157537. pmid:25501809.
- 53. Matsumoto A, Onoyama I, Sunabori T, Kageyama R, Okano H, Nakayama KI. Fbxw7-dependent Degradation of Notch Is Required for Control of "Stemness" and Neuronal-Glial Differentiation in Neural Stem Cells. J Biol Chem. 2011;286(15):13754–64. https://doi.org/10.1074/jbc.M110.194936. pmid:21349854.
- 54. Hoeck JD, Jandke A, Blake SM, Nye E, Spencer-Dene B, Brandner S, et al. Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun. Nat Neurosci. 2010;13(11):1365–72. https://doi.org/10.1038/nn.2644. pmid:20935640.
- 55. Bogoyevitch MA, Yeap YYC, Qu ZD, Ngoei KR, Yip YY, Zhao TT, et al. WD40-repeat protein 62 is a JNK-phosphorylated spindle pole protein required for spindle maintenance and timely mitotic progression. J Cell Sci. 2012;125(21):5096–109. https://doi.org/10.1242/jcs.107326. pmid:22899712.
- 56. Gutierrez GJ, Tsuji T, Chen MF, Jiang W, Ronai ZA. Interplay between Cdh1 and JNK activity during the cell cycle. Nature Cell Biology. 2010;12(7):686–U130. https://doi.org/10.1038/ncb2071. pmid:20581839
- 57. Fish JL, Kosodo Y, Enard W, Paabo S, Huttner WB. Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cells. Proc Natl Acad Sci U S A. 2006;103(27):10438–43. https://doi.org/10.1073/pnas.0604066103. pmid:16798874.
- 58. Lizarraga SB, Margossian SP, Harris MH, Campagna DR, Han AP, Blevins S, et al. Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors. Development. 2010;137(11):1907–17. https://doi.org/10.1242/dev.040410. pmid:20460369.
- 59. Manzini MC, Walsh CA. What disorders of cortical development tell us about the cortex: one plus one does not always make two. Curr Opin Genet Dev. 2011;21(3):333–9. https://doi.org/10.1016/j.gde.2011.01.006. pmid:21288712
- 60. Wollnik B. A common mechanism for microcephaly. Nat Genet. 2010;42(11):923–4. https://doi.org/10.1038/ng1110-923. pmid:20980985.
- 61. Buchman JJ, Tseng HC, Zhou Y, Frank CL, Xie Z, Tsai LH. Cdk5rap2 interacts with pericentrin to maintain the neural progenitor pool in the developing neocortex. Neuron. 2010;66(3):386–402. https://doi.org/10.1016/j.neuron.2010.03.036. pmid:20471352.
- 62. Gruber R, Zhou ZW, Sukchev M, Joerss T, Frappart PO, Wang ZQ. MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway. Nat Cell Biol. 2011;13(11):1325–U100. https://doi.org/10.1038/ncb2342. pmid:21947081.
- 63. Buchman JJ, Durak O, Tsai LH. ASPM regulates Wnt signaling pathway activity in the developing brain. Genes Dev. 2011;25(18):1909–14. https://doi.org/10.1101/gad.16830211. pmid:21937711.
- 64. Yamasaki T, Kawasaki H, Arakawa S, Shimizu K, Shimizu S, Reiner O, et al. Stress-activated protein kinase MKK7 regulates axon elongation in the developing cerebral cortex. J Neurosci. 2011;31(46):16872–83. https://doi.org/10.1523/JNEUROSCI.1111-11.2011. pmid:22090513.
- 65. Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 2001;294(5540):173–7. https://doi.org/10.1126/science.1065203. pmid:11533444.
- 66. Nyabi O, Naessens M, Haigh K, Gembarska A, Goossens S, Maetens M, et al. Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells. Nucleic Acids Research. 2009;37(7).
- 67. Sun Y, Fei T, Yang T, Zhang F, Chen YG, Li H, et al. The suppression of CRMP2 expression by bone morphogenetic protein (BMP)-SMAD gradient signaling controls multiple stages of neuronal development. J Biol Chem. 2010;285(50):39039–50. https://doi.org/10.1074/jbc.M110.168351. pmid:20926379.